Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Will

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
The Lancet. Neurology|April 25, 2006
Predicting susceptibility and incubation time of human-to-human transmission of vCJDM T Bishop, P Hart, L Aitchison, et al.
Neurology|December 15, 2004
A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clusteringL Linsell, S N Cousens, P G Smith, et al.
European Journal of Neurology|August 8, 2008
MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement studyA Krasnianski, K Kallenberg, D A Collie, et al.
Nature|October 23, 1997
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agentM E Bruce, R G Will, J W Ironside, et al.
Lancet (London, England)|May 3, 2000
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob diseaseM Zeidler, R J Sellar, D A Collie, et al.
Lancet (London, England)|October 7, 1997
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic testsM Zeidler, G E Stewart, C R Barraclough, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2006
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UKC A Heath, R A Barker, T F G Esmonde, et al.
Neurology|November 9, 2000
Iatrogenic Creutzfeldt-Jakob disease at the millenniumP Brown, M Preece, J P Brandel, et al.
Lancet (London, England)|July 11, 1998
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD)C M van Duijn, N Delasnerie-Lauprêtre, C Masullo, et al.
Nature|July 17, 1997
Molecular assessment of the potential transmissibilities of BSE and scrapie to humansG J Raymond, J Hope, D A Kocisko, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
The Lancet. Neurology|April 25, 2006
Predicting susceptibility and incubation time of human-to-human transmission of vCJDM T Bishop, P Hart, L Aitchison, et al.
Neurology|December 15, 2004
A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of clusteringL Linsell, S N Cousens, P G Smith, et al.
European Journal of Neurology|August 8, 2008
MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement studyA Krasnianski, K Kallenberg, D A Collie, et al.
Nature|October 23, 1997
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agentM E Bruce, R G Will, J W Ironside, et al.
Lancet (London, England)|May 3, 2000
The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob diseaseM Zeidler, R J Sellar, D A Collie, et al.
Lancet (London, England)|October 7, 1997
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic testsM Zeidler, G E Stewart, C R Barraclough, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2006
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UKC A Heath, R A Barker, T F G Esmonde, et al.
Neurology|November 9, 2000
Iatrogenic Creutzfeldt-Jakob disease at the millenniumP Brown, M Preece, J P Brandel, et al.
Lancet (London, England)|July 11, 1998
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD)C M van Duijn, N Delasnerie-Lauprêtre, C Masullo, et al.
Nature|July 17, 1997
Molecular assessment of the potential transmissibilities of BSE and scrapie to humansG J Raymond, J Hope, D A Kocisko, et al.
Pageof 14